Situation analysis study on nanomedicines regulation and assessment practices in Zazibona active countries
Loading...
Date
2021
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
University of Western Cape
Abstract
Nanomedicines are loosely defined as medicines that seek to apply nanotechnology. Currently,
nanomedicines are available for clinical use, including treatments for cancer, high cholesterol,
hepatitis, COVID-19 vaccination, among other uses (Patra et al., 2018; Gao et al., 2021). Most
of the nanomedicines meet the definition of medicines according to various national
legislations. Consequently, these products are regulated as medicines. Nanomedicines present
major differences in biological details and increased complexity of clinical use. They integrate
different technology subsets from therapeutics to imaging and integrated non-invasive
diagnosis (Gaspar, 2007). These complexities require extra regulatory effort.
Description
>Magister Scientiae - MSc
Keywords
Nanomedicines, Medicines legislation, Medicines assessment practices, Medicines registration, Zazibona